News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
BioSpace News Archive
Browse BioSpace’s published news and press releases by year, month, and day.
150 Results
Year
2005 (24679)
2006 (34770)
2007 (39687)
2008 (39410)
2009 (42118)
2010 (39616)
2011 (38383)
2012 (38416)
2013 (36268)
2014 (39673)
2015 (44433)
2016 (38330)
2017 (37190)
2018 (39124)
2019 (51338)
2020 (57666)
2021 (58724)
2022 (53929)
2023 (42568)
2024 (38485)
2025 (24953)
Month
January (2883)
February (2030)
March (1769)
April (2200)
May (2664)
June (3162)
July (3087)
August (3801)
September (4260)
October (5136)
November (4629)
December (3503)
Day
1 (168)
2 (76)
4 (3)
5 (150)
6 (144)
7 (139)
8 (146)
9 (72)
10 (4)
11 (1)
12 (157)
13 (167)
14 (125)
15 (111)
16 (54)
17 (4)
19 (20)
20 (49)
21 (57)
22 (62)
23 (38)
25 (1)
26 (79)
27 (106)
28 (97)
Year
2005
2006
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Month
January
February
March
April
May
June
July
August
September
October
November
December
Day
1
2
4
5
6
7
8
9
10
11
12
13
14
15
16
17
19
20
21
22
23
25
26
27
28
Merial, Now Part of Boehringer Ingelheim, Grows Canine Vaccine Portfolio With Introduction of RECOMBITEK Oral Bordetella
RECOMBITEK vaccines are manufactured by Merial. Merial is now a part of Boehringer Ingelheim.
February 5, 2018
·
3 min read
Business
Poseida Therapeutics Appoints Martin Giedlin, Ph.D., as Vice President, Technical Operations
Dr. Giedlin brings significant expertise in cell therapy process development, manufacturing, and strategy in immunotherapies.
February 5, 2018
·
2 min read
Business
Bellicum Pharmaceuticals Appoints Dr. William Grossman as CMO
Dr. Grossman joins Bellicum from Genentech/Roche.
February 5, 2018
·
5 min read
Biotech Beach
PAA Showcases its Most Complete Range of Laboratory Automation Solutions at SLAS2018
S-CEL robotic systems combine modular configuration, containment options and environmental control to make a comprehensive, integrated laboratory automation solution.
February 5, 2018
·
2 min read
Drug Development
Immunicum AB Presents Case Study of One Patient From Phase I/II HCC Trial at Cholangiocarcinoma Foundation Annual Conference
In the study, the bile duct cancer patient first received a transarterial chemo-embolization (TACE), which is a standard method to deliver a chemotherapeutic drug directly to the tumor while also restricting blood supply to the tumor.
February 5, 2018
·
4 min read
Business
Prothena Announces Departure of CMO
The Company is commencing a search for a replacement.
February 5, 2018
·
2 min read
Biotech Beach
New Focal Charge Compensation Mode for ZEISS Field Emission Scanning Electron Microscopes Improves Image Quality
In collaboration with theNCMIR at the University of California San Diego, ZEISS releases a new Focal Charge Compensation module for block face imaging with ZEISS GeminiSEM and 3View from Gatan, Inc.
February 5, 2018
·
1 min read
Business
AbbVie and MBC BioLabs Team Up to Support Life-Science Startups in the San Francisco Bay Area
AbbVie and MBC BioLabs announced that they have teamed up to help support and mentor promising startups.
February 5, 2018
·
2 min read
GB Sciences Files a Nonprovisional Patent Application for Cannabis-Based Anti-Inflammatory Therapies Including Arthritis, Asthma, Eczema and More
The new patent application claims the benefit of GB Sciences’ provisional patent previously filed on February 1, 2017.
February 5, 2018
·
3 min read
Lone Star Bio
NanOlogy to Update Clinical Program Transforming Treatment of Cancer at BIO CEO and Investor Conference
NanOlogy announced today that Gere diZerega, MD, VP of Medical Affairs, will present at BIO CEO & Investor Conference, February 12, 2018, at 3:15 PM EST in the Brecht room of the New York Marriott Marquis.
February 5, 2018
·
4 min read
Previous
6 of 15
Next